378 related articles for article (PubMed ID: 24167019)
41. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.
Cohen-Cymberknoh M; Blau H; Shoseyov D; Mei-Zahav M; Efrati O; Armoni S; Kerem E
J Cyst Fibros; 2009 Jul; 8(4):253-7. PubMed ID: 19447081
[TBL] [Abstract][Full Text] [Related]
42. [Clinical features of cystic fibrosis associated allergic bronchopulmonary aspergillosis in children].
Shen YL; Chen QH; Tang XL; Xu H; Li HM; Zhao SY
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):646-652. PubMed ID: 32842385
[No Abstract] [Full Text] [Related]
43. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients.
de Almeida MB; Bussamra MH; Rodrigues JC
Paediatr Respir Rev; 2006 Mar; 7(1):67-72. PubMed ID: 16473820
[TBL] [Abstract][Full Text] [Related]
44. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.
Mastella G; Rainisio M; Harms HK; Hodson ME; Koch C; Navarro J; Strandvik B; McKenzie SG
Eur Respir J; 2000 Sep; 16(3):464-71. PubMed ID: 11028661
[TBL] [Abstract][Full Text] [Related]
45. Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/mL.
Knutsen AP; Noyes B; Warrier MR; Consolino J
Ann Allergy Asthma Immunol; 2005 Nov; 95(5):488-93. PubMed ID: 16312174
[TBL] [Abstract][Full Text] [Related]
46. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges.
Delhaes L; Frealle E; Pinel C
Med Mycol; 2010 Nov; 48 Suppl 1():S77-87. PubMed ID: 21067334
[TBL] [Abstract][Full Text] [Related]
47. Potential benefit of omalizumab in respiratory diseases.
Bonini M; Di Maria G; Paggiaro P; Rossi A; Senna G; Triggiani M; Canonica GW
Ann Allergy Asthma Immunol; 2014 Nov; 113(5):513-9. PubMed ID: 25442695
[TBL] [Abstract][Full Text] [Related]
48. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Epps QJ; Epps KL; Zobell JT; Young DC
Pediatr Pulmonol; 2020 Dec; 55(12):3541-3572. PubMed ID: 32946194
[TBL] [Abstract][Full Text] [Related]
49. Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.
Brinkmann F; Schwerk N; Hansen G; Ballmann M
Allergy; 2010 Jan; 65(1):134-5. PubMed ID: 19804448
[No Abstract] [Full Text] [Related]
50. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
Lin RY; Sethi S; Bhargave GA
J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness and Safety of Omalizumab in Patients with Allergic Bronchopulmonary Aspergillosis Complicated by Chronic Bacterial Infection in the Airways.
Tomomatsu K; Oguma T; Baba T; Toyoshima M; Komase Y; Taniguchi M; Asano K;
Int Arch Allergy Immunol; 2020; 181(7):499-506. PubMed ID: 32388510
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
Skov M; McKay K; Koch C; Cooper PJ
Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
[TBL] [Abstract][Full Text] [Related]
53. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Hartl D; Latzin P; Zissel G; Krane M; Krauss-Etschmann S; Griese M
Am J Respir Crit Care Med; 2006 Jun; 173(12):1370-6. PubMed ID: 16543550
[TBL] [Abstract][Full Text] [Related]
54. Aspergillus bronchitis in cystic fibrosis.
Shoseyov D; Brownlee KG; Conway SP; Kerem E
Chest; 2006 Jul; 130(1):222-6. PubMed ID: 16840406
[TBL] [Abstract][Full Text] [Related]
55. Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Gernez Y; Waters J; Mirković B; Lavelle GM; Dunn CE; Davies ZA; Everson C; Tirouvanziam R; Silver E; Wallenstein S; Chotirmall SH; McElvaney NG; Herzenberg LA; Moss RB
Eur Respir J; 2016 Jan; 47(1):177-85. PubMed ID: 26585435
[TBL] [Abstract][Full Text] [Related]
56. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
Thia LP; Balfour Lynn IM
Paediatr Respir Rev; 2009 Mar; 10(1):37-42. PubMed ID: 19203743
[TBL] [Abstract][Full Text] [Related]
57. Serum immunoglobulins E and G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis.
Knutsen AP; Hutcheson PS; Mueller KR; Slavin RG
J Lab Clin Med; 1990 Nov; 116(5):724-7. PubMed ID: 2230542
[TBL] [Abstract][Full Text] [Related]
58. Allergic bronchopulmonary aspergillosis in children.
Manti S; Parisi GF; Papale M; Licari A; Chiappini E; Mulè E; Rotolo N; Leonardi S
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():20-22. PubMed ID: 33236425
[TBL] [Abstract][Full Text] [Related]
59. Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases.
Aydın Ö; Sözener ZÇ; Soyyiğit Ş; Kendirlinan R; Gençtürk Z; Mısırlıgil Z; Mungan D; Sin BA; Demirel YS; Çelik GE; Bavbek S
Allergy Asthma Proc; 2015; 36(6):493-500. PubMed ID: 26534756
[TBL] [Abstract][Full Text] [Related]
60. [Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF): clinical significance, diagnosis and therapy].
Paul KD; Leupold W; Blaschke-Hellmessen R; Ulbrich K; Peter-Kern M; Neumeister V
Mycoses; 1996; 39 Suppl 1():55-8. PubMed ID: 8767272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
